John M. Gay

VP, Finance & Corp. Controller, NVN Liquidation, Inc.

Companies

Pelthos Therapeutics Inc.Chief financial officer Apr 20, 2026 to now¹
NVN Liquidation, Inc.Chief financial officer May 19, 2021 to Jun 8, 2023²
NVN Liquidation, Inc.VP, Finance & Corp. Controller Jan 31, 2019 to Apr 8, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pelthos Therapeutics Inc. PTHS30,518 shares⁴$616.5K at $20.20Apr 20, 2026
NVN Liquidation, Inc.46,831 shares⁵Jun 7, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 7, 2023Shares withheld for tax 20,669 shares of NVN Liquidation, Inc.⁵
Jun 7, 2023Exercised options 65,000 shares of NVN Liquidation, Inc.⁵
Mar 18, 2022Bought 1,000 shares at $3.50 of NVN Liquidation, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPelthos Therapeutics Inc., Chief financial officer
2
SEC EDGARNVN Liquidation, Inc., Chief financial officer
3
SEC EDGARNVN Liquidation, Inc., VP, Finance & Corp. Controller
4
SEC EDGARPelthos Therapeutics Inc. shares after the filing of Apr 20, 2026
5
SEC EDGARNVN Liquidation, Inc. shares after the filing of Jun 7, 2023
6
SEC EDGARForm 4 filed Mar 22, 2022